Selskabets formål er at drive virksomhed inden for udvikling og fremstilling af samt handel med biomolekyler til den farmaceutiske industri og ernæringsindustrien.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | 1.5 mio. | 669.9 mio. | 508.5 mio. | 108 | |
CVR: 37207713
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 24 companies in Fremstilling af farmaceutiske råvarer
Comparison is based on industry median values
Companies in the same industry and area
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB appointed as auditor
KPMG P/S resigned as auditor